Interventional Cardiology Unit, San Luigi Gonzaga University Hospital (Orbassano) and Rivoli Infermi Hospital (Rivoli), Turin, Italy; Montefiore Medical Center, New York, New York.
Cardiology Unit, Santissima Annunziata Hospital, ASL CN1, Savigliano (CN), Italy.
Am J Cardiol. 2021 Mar 15;143:37-45. doi: 10.1016/j.amjcard.2020.12.041. Epub 2020 Dec 30.
Ellis grade III coronary artery perforations (G3-CAP) remain a life-threatening complication of percutaneous coronary intervention (PCI), with high morbidity and mortality and lack of consensus regarding optimal treatment strategies. We reviewed all PCIs performed in 10 European centers from 1993 to 2019 recording all G3-CAP along with management strategies, in-hospital and long-term outcome according to Device-related perforations (DP) and Guidewire-related perforations (WP). Among 106,592 PCI (including 7,773 chronic total occlusions), G3-CAP occurred in 311 patients (0.29%). DP occurred in 194 cases (62.4%), more commonly in proximal segments (73.2%) and frequently secondary to balloon dilatation (66.0%). WP arose in 117 patients (37.6%) with chronic total occlusions guidewires involved in 61.3% of cases. Overall sealing success rate was 90.7% and usually required multiple maneuvers (80.4%). The most commonly adopted strategies to obtain hemostasis were prolonged balloon inflation (73.2%) with covered stent implantation (64.4%) in the DP group, and prolonged balloon inflation (53.8%) with coil embolization (41%) in the WP group. Procedural or in-hospital events arose in 38.2% of cases: mortality was higher after DP (7.2% vs 2.6%, p = 0.05) and acute stent thrombosis 3-fold higher (3.1% vs 0.9%, p = 0.19). At clinical follow-up, median 2 years, a major cardiovascular event occurred in one-third of cases (all-cause mortality 8.2% and 7.1% respectively, without differences between groups). In conclusion, although rare and despite improved rates of adequate perforation sealing G3-CAP cause significant adverse events. DP and WP result in different patterns of G3-CAP and management strategies should be based on this classification.
III 级(Ellis 分级)冠状动脉穿孔(G3-CAP)仍然是经皮冠状动脉介入治疗(PCI)的一种危及生命的并发症,具有较高的发病率和死亡率,并且对于最佳治疗策略缺乏共识。我们回顾了 1993 年至 2019 年在 10 个欧洲中心进行的所有 PCI,记录了所有 G3-CAP 以及根据器械相关穿孔(DP)和导丝相关穿孔(WP)的管理策略、住院期间和长期结果。在 106592 例 PCI(包括 7773 例慢性完全闭塞)中,311 例患者出现 G3-CAP(0.29%)。DP 发生在 194 例患者中(62.4%),更常见于近端节段(73.2%),常继发于球囊扩张(66.0%)。WP 发生在 117 例患者中(37.6%),其中 61.3%的病例涉及慢性完全闭塞导丝。总体封堵成功率为 90.7%,通常需要多次操作(80.4%)。最常采用的止血策略是 DP 组延长球囊扩张(73.2%)联合覆膜支架植入(64.4%),WP 组延长球囊扩张(53.8%)联合线圈栓塞(41%)。38.2%的病例出现了操作或住院期间的事件:DP 后死亡率更高(7.2%比 2.6%,p=0.05),急性支架血栓形成的风险增加 3 倍(3.1%比 0.9%,p=0.19)。在临床随访中,中位 2 年,三分之一的病例发生了主要心血管事件(全因死亡率分别为 8.2%和 7.1%,两组之间无差异)。总之,尽管 G3-CAP 罕见,且尽管穿孔封堵的成功率有所提高,但仍会导致严重的不良事件。DP 和 WP 导致不同类型的 G3-CAP,应根据这一分类制定治疗策略。